|
Targeting cancer-specific non-protein molecular signatures for immunotherapy of pediatric AML
|
Hackensack Meridian Health Center for Discovery and Innovation |
The Mya Lin Terry Foundation |
|
IL7 signaling enhanced CAR T cells to treat pediatric solid tumors |
Baylor College of Medicine |
Northwestern Mutual Foundation |
|
Incidence and grades of adverse events during treatment for pediatric acute lymphoblastic leukemia |
Emory University |
Northwestern Mutual Foundation |
|
Identification of phenotypic effects of genomic changes in retinoblastoma tumors using an aqueous humor liquid biopsy |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
|
Effects of standardized, prospective Epstein-Barr virus (EBV) monitoring on the natural history and outcomes of post-transplant lymphoproliferative disorder and EBV-associated smooth muscle tumor in pediatric solid organ transplantation patients |
Children’s Hospital of Philadelphia |
Northwestern Mutual Foundation |
|
Therapeutic targeting of clonal hematopoiesis in RUNX1 mutant FPDMM |
University of Pennsylvania |
The RUNX1 Research Program |
|
Epigenetic control of cell state in retinoid resistant neuroblastoma |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
|
Targeting and imaging immunometabolic vulnerabilities in diffuse midline glioma |
The Regents of the University of California San Francisco |
Storm The Heavens Fund |
|
The role of reactive gliosis in response to Immunotherapy in Diffuse Midline Glioma |
University of Florida |
Little Hero Foundation |
|
Development of allogeneic off-the-shelf gamma delta T cell product for pediatric AML |
Baylor College of Medicine |
Little Hero Foundation |
